Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / PHARMACEUTCL ETF
-
Total 13F shares
-
5,722,368
-
Share change
-
+906,889
-
Total reported value
-
$543,596,181
-
Put/Call ratio
-
58%
-
Price per share
-
$95.03
-
Number of holders
-
140
-
Value change
-
+$86,910,938
-
Number of buys
-
71
-
Number of sells
-
60
Institutional Holders of VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) as of Q3 2024
As of 30 Sep 2024,
VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) was held by
140 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,722,368 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, Avalon Trust Co, Mirae Asset Global Investments Co., Ltd., Thrivent Financial for Lutherans, Miller Investment Management, LP, NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO, Prime Capital Investment Advisors, LLC, BANK OF AMERICA CORP /DE/, and Financial Partners Group, Inc.
This page lists
140
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.